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R918General Anesthesia: Activating
a Sleep Switch?A widely used general anesthetic directly depolarizes sleep-promoting cells
in the brain at doses that produce unconsciousness. The activation of an
endogenous sleep pathway likely plays a role in general anesthesia.Ken Solt
General anesthesia is a reversible,
drug-induced state characterized by
amnesia, unconsciousness, analgesia
(loss of pain sensation), and lack of
movement in the setting of stable
physiological systems [1]. In the United
States alone,more than 100,000 people
receive general anesthesia every day,
and most of us will experience it at
some point in our lives. Since the
first successful public demonstration
of general anesthesia in 1846,
physicians and scientists have sought
to understand how anesthetics work.
In this issue of Current Biology, Moore
and colleagues [2] add another piece to
the puzzle: they have discovered that
the commonly used general anesthetic
isoflurane directly activates a subset
of cells in the ventral lateral preoptic
area (VLPO) of the brain that promote
natural sleep.
From Molecules to Neural Circuits
A variety of chemical compounds
including ethers, alkanes, phenols,
and even the noble gas xenon are
capable of inducing the state of
general anesthesia. In the late 1800s,
Claude Bernard proposed a unitary
mechanism for general anesthesia,
and soon afterwards, a strong
correlation between anesthetic
potency and hydrophobicity was
reported [3]. This led to the widespread
acceptance of unitary, lipid-based
theories of general anesthesia that
dominated thinking in the field for
almost a century.
By the mid-1980s, it was apparent
that proteins, not lipids, are the likely
targets of general anesthetics [4]. Still
strongly guided by the principles of
classical pharmacology and the
notion of a unitary mechanism,
efforts in the field were refocused
towards identifying the protein target
responsible for general anesthesia. A
plethora of data emerged describing
anesthetic effects on putative sites
of action such as neuronal receptors
and ion channels [5].It soon became evident that
anesthetics bind to (and alter the
function of) a wide variety of relevant
proteins at clinical concentrations. In
most cases, general anesthetics
enhance inhibitory ion channels such
as g-aminobutyric acid type A (GABAA)
receptors, inhibit excitatory ion
channels such as glutamate receptors,
or both [6]. Although genetically altered
mice have been used successfully to
demonstrate that the intravenous
general anesthetics propofol and
etomidate produce unconsciousness
via actions at GABAA receptors [7], no
such data exist for other anesthetic
drugs. Proving a causal relationship
between anesthetic effects observed
at the molecular level and the specific
behaviors that define general
anesthesia remains a major challenge.
In the early 1990s, it was discovered
that general anesthetics ablate
movement in response to pain by
inhibiting neurons in the spinal cord,
rather than the brain [8,9]. This
important finding proved that general
anesthetics produce specific behaviors
at distinct neuroanatomical sites.
That is, the endpoints that define
general anesthesia (amnesia,
unconsciousness, analgesia and lack
of movement) are created in different
parts of the central nervous system
(such as lack of movement in the
spinal cord). To better understand
their complex actions on the central
nervous system, recent work has
focused on studying the actions of
anesthetics at the level of neural
circuits and systems.
General Anesthesia and Sleep
Sleep is a comforting metaphor that
is often used by anesthesiologists
to describe the state of general
anesthesia to patients, although in
reality general anesthesia is more akin
to a coma [1]. Although sleep and
general anesthesia are both states that
involve unconsciousness, sufficient
stimulation will wake up any sleeping
animal, whereas by design in a state
of general anesthesia even severelynoxious stimulation will not induce an
arousal response. However, because it
is now evident that individual behaviors
are induced by anesthetics at distinct
neuroanatomical sites, efforts to
understand the specific endpoint of
unconsciousness have focused on
sites in the brain that regulate sleep
and wakefulness.
There are numerous sites and
neurotransmitters in the brain that
promote behavioral arousal, including
acetylcholine-releasing cells in the
pedunculopontine and laterodorsal
tegmental areas, histamine-releasing
cells in the tuberomammilary nucleus,
norepinephrine-releasing cells in the
locus ceruleus, and others [10].
Arousal-promoting neurons activate
the thalamus and cortex to maintain
wakefulness, and also inhibit
sleep-promoting neurons [11]. There
is accumulating evidence that these
arousal-promoting pathways are
important for emergence from general
anesthesia [12]. For instance, patients
suffering from narcolepsy (a rare
sleep disorder caused by the loss of
wake-promoting orexinergic neurons)
are abnormally slow to wake up from
general anesthesia [13], and
orexin-deficient mice show similar
traits [14]. Conversely, activation
of cholinergic [15] and dopaminergic
[16] arousal pathways can induce
emergence from general anesthesia
in animals.
During natural sleep, neurons in
the VLPO and median preoptic
area are active and release the
neurotransmitters GABA and galanin
to inhibit arousal-promoting neurons
[11,12,17]. Earlier work showed that
anesthetics increase activity in VLPO
neurons [18,19], but it was unclear
whether anesthetics directly activate
VLPO neurons, or indirectly activate
them by inhibiting arousal-promoting
neurons. The latter hypothesis
has been favored, since general
anesthetics are usually thought to
produce their effects on the central
nervous system through neuronal
inhibition, not excitation.
Direct Activation of a Sleep Pathway
Moore et al. [2] used c-Fos expression
as amarker of neuronal activity to show
that VLPO neurons are more active in
mice during both natural sleep and
isoflurane anesthesia, compared to the
awake state. Isoflurane activation of
VLPO neurons was dose-dependent
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R919and, more importantly, correlated with
behavior, as a low dose insufficient
to induce unconsciousness also failed
to significantly increase VLPO activity.
In addition, VLPO lesions in mice
produced an acute resistance to
isoflurane-induced unconsciousness,
further suggesting that VLPO neurons
are a target for isoflurane. However,
while c-Fos and lesion data may be
suggestive of a mechanism, they are
not definitive.
The highlight of this paper [2] is
the electrophysiological work using
hypothalamic slices. The authors
report that isoflurane selectively
depolarized NA(–) cells, the subtype of
VLPO neurons thought to promote
sleep. Surprisingly, the excitatory
effects of isoflurane were
extrasynaptic. In other words, rather
than indirectly activating VLPO neurons
through synaptic inputs, isoflurane
directly depolarized VLPO neurons.
The authors go a step further and show
that closure of a background
potassium conductance is the likely
mechanism.
The vast majority of
electrophysiological work to date has
found that anesthetics enhance
inhibitory receptors or inhibit excitatory
receptors, and in either case the
common end result is neuronal
depression. Although direct activation
of central respiratory chemoreceptor
neurons by isoflurane has been
previously reported [20], direct
anesthetic-induced depolarization of
neurons is a highly unusual finding.
More importantly, the discovery that
isoflurane selectively activates
sleep-promoting NA(–) neurons in the
VLPO supports an emerging concept
that anesthetics contribute to
unconsciousness through specific
effects at discrete neural circuits that
regulate sleep and wakefulness.
Future Directions
The mechanisms of general anesthesia
have evolved from an elusive
pharmacology puzzle to a tractable
neuroscience problem. Despite
considerable advances in our
knowledge of the molecular effects
of anesthetics, much remains to be
learned about the profound and
complex changes that occur at the
level of neural circuits and systems
during general anesthesia. With our
current knowledge of the molecular
mechanisms of general anesthesia and
the neurobiology of arousal, it hasbecome feasible to apply a systems
neuroscience analysis to the problem
[17]. Such analyses will provide
a framework to explore and better
understand the mechanisms of general
anesthesia.References
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a Root?The plant hormone cytokinin controls root growth by balancing the division and
differentiation of stem cells. But what controls accumulation of cytokinin?
A new study has identified a regulatory loop between a transcription factor,
PHABULOSA, and cytokinin biosynthesis that creates robust domains of
cytokinin activity.Anthony Bishopp1,
Robertas Ursache2,
and Yka¨ Helariutta2,*
Root growth is a highly variable
process that is dependent on
environmental stimuli. It iscoordinated by a small population of
undifferentiated stem cells close to the
root tip (known as themeristem). These
cells undergo several rounds of cell
division before they elongate and finally
differentiate [1]. The rate of root growth
and the size of the meristem are
